Creteil, France

Gilles Monnier

This inventor holds 1 USPTO granted patent. Top assignee: Laboratoire Roger Bellon. Active years: 1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gilles Monnier. Retrieved from https://idiyas.com/inventor/gilles-monnier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gilles Monnier: Innovator in Medicinal Chemistry

Introduction

Gilles Monnier is a notable inventor based in Créteil, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patent work. His research focuses on developing compounds that have potential therapeutic applications.

Latest Patents

Gilles Monnier holds a patent for "1-Aryl-4-.gamma.-arylsulphonyl-3-aminopropoxy-1H-pyrazoles and their use." This patent describes compounds that can be utilized as medicaments, specifically as hypolipemiant or hypocholesterolemiant agents. The compounds are characterized by their unique chemical structure and their acid addition salts.

Career Highlights

Monnier's career is marked by his dedication to advancing medicinal chemistry. He has successfully developed a patent that addresses important health issues related to cholesterol and lipid levels in the body. His work has the potential to contribute significantly to the pharmaceutical industry.

Collaborations

Throughout his career, Gilles Monnier has collaborated with esteemed colleagues such as Henri Techer and Marcel E. Pesson. These collaborations have fostered a productive environment for innovation and research in medicinal chemistry.

Conclusion

Gilles Monnier's contributions to the field of medicinal chemistry through his patent work exemplify his commitment to improving health outcomes. His innovative compounds hold promise for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…